Exact Mass: 429.1305

Besifloxacin HCl

C19H22Cl2FN3O3 (429.1022)

D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

Pizotifen malate

C23H27NO5S (429.161)

Pizotifen malate (Pizotyline malate) is a potent 5-HT2 receptor antagonist, with a high affinity for 5-HT1C binding site.

Sulfamethoxazole N1-glucuronide

C16H19N3O9S (429.0842)

Sulfamethoxazole N1-glucuronide is a metabolite of Sulfamethoxazole. Sulfamethoxazole n1-glucuronide belongs to the family of Phenols and Derivatives. These are compounds containing a phenol moiety, which is a benzene bearing an hydroxyl group.

Azalanstat

C22H24ClN3O2S (429.1278)

Azeloprazole

C22H27N3O4S (429.1722)

StemRegenin 1

C24H23N5OS (429.1623)

Zofenopril

C22H23NO4S2 (429.1068)

trans-zeatin riboside monophosphate

C15H20N5O8P (429.1049)

Cis-zeatin riboside monophosphate is a member of the class of compounds known as purine ribonucleoside monophosphates. Purine ribonucleoside monophosphates are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Cis-zeatin riboside monophosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Cis-zeatin riboside monophosphate can be found in a number of food items such as lichee, swiss chard, catjang pea, and teff, which makes cis-zeatin riboside monophosphate a potential biomarker for the consumption of these food products.

LYCOGARUBIN B

C24H19N3O5 (429.1325)

Periglaucine D

C23H27NO7 (429.1787)

A natural product found in Pericampylus glaucus.

Cottoquinazoline A

C23H19N5O4 (429.1437)

CHEMBL208310

C23H27NO7 (429.1787)

Q63396586

C17H15N7O5S (429.0855)

TCMDC-134227

C25H23N3O2S (429.1511)

Antibiotic FD 839

C22H23NO8 (429.1424)

beta-D-glucopyranuronic acid 3-(2-amino-4-oxo-3,4-dihydro-pteridin-6-yl)-2,3-dihydroxy-propyl ester|Neopterin-3-beta-D-glucuronid

C15H19N5O10 (429.1132)

Tetra-Me ether,Me ester-Clovamide

C23H27NO7 (429.1787)

14N-Ac-9-[(2-Amino-2-carboxyethyl)thio]-10-hydroxy-3,5,7-tetradecatrienedioic acid

C19H27NO8S (429.1457)

Serranticin

C21H23N3O7 (429.1536)

(5R)-3-methyl-2(5H)furanone-(5->6)-(6R)-5,6-dihydrosanguinarine|maclekarpine C

C25H19NO6 (429.1212)

N-Methyloxohydrasteine

C22H23NO8 (429.1424)

SCHEMBL7153244

C19H19N5O7 (429.1284)

C23H27NO7

C23H27NO7 (429.1787)

DTXSID20825858

C22H23NO8 (429.1424)

ehretioside A1

C19H27NO10 (429.1635)

oxocoryrutine

C22H23NO8 (429.1424)

acuminaminoside

C22H23NO8 (429.1424)

(-)-trans-2-fluorocyclohexyl-N-[p-(4-methyl-beta-D-glucopyranosyl)]phenyl-carbamate

C20H28FNO8 (429.1799)

C22H23NO8

C22H23NO8 (429.1424)

7beta-senecioyloxy-9-(5-senecioyloxy angeloyloxy)-5,8-dehydroheliotridin-5-one|7beta-senecioyloxy-9-<5-senecioyloxy angeloyloxy>-5,8-dehydroheliotridin-5-one

C23H27NO7 (429.1787)

Methoxymecambridine

C23H27NO7 (429.1787)

pGlu-Asn-Trp

C20H23N5O6 (429.1648)

Methylhydrasteine methyl ester

C23H27NO7 (429.1787)

ehretioside A3

C19H27NO10 (429.1635)

ehretioside A2

C19H27NO10 (429.1635)

mecambridine

C23H27NO7 (429.1787)

Erlotinib HCL

C22H24ClN3O4 (429.1455)

Pefloxacin mesylate

C18H24FN3O6S (429.137)

L - Antineoplastic and immunomodulating agents > L03 - Immunostimulants > L03A - Immunostimulants > L03AA - Colony stimulating factors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic

Besifloxacin HCl (Besivance)

C19H22Cl2FN3O3 (429.1022)

SMZ-PtO

C17H15N7O5S (429.0855)

CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b); ALGAE_TP_ID 3103 ALGAE_TP_ID 3103; CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b)

MMV024035

C25H23N3O2S (429.1511)

Dereplicator+ Identification - Serratiochelin

C21H23N3O7 (429.1536)

Cys Gly His Asn

C15H23N7O6S (429.143)

Cys Gly Asn His

C15H23N7O6S (429.143)

Cys His Gly Asn

C15H23N7O6S (429.143)

Cys His Asn Gly

C15H23N7O6S (429.143)

Cys Asn Gly His

C15H23N7O6S (429.143)

Cys Asn His Gly

C15H23N7O6S (429.143)

Cys Asn Pro Pro

C17H27N5O6S (429.1682)

Cys Pro Asn Pro

C17H27N5O6S (429.1682)

Cys Pro Pro Asn

C17H27N5O6S (429.1682)

Gly Cys His Asn

C15H23N7O6S (429.143)

Gly Cys Asn His

C15H23N7O6S (429.143)

Gly His Cys Asn

C15H23N7O6S (429.143)

Gly His Asn Cys

C15H23N7O6S (429.143)

Gly Asn Cys His

C15H23N7O6S (429.143)

Gly Asn His Cys

C15H23N7O6S (429.143)

His Cys Gly Asn

C15H23N7O6S (429.143)

His Cys Asn Gly

C15H23N7O6S (429.143)

His Gly Cys Asn

C15H23N7O6S (429.143)

His Gly Asn Cys

C15H23N7O6S (429.143)

His Asn Cys Gly

C15H23N7O6S (429.143)

His Asn Gly Cys

C15H23N7O6S (429.143)

Asn Cys Gly His

C15H23N7O6S (429.143)

Asn Cys His Gly

C15H23N7O6S (429.143)

Asn Cys Pro Pro

C17H27N5O6S (429.1682)

Asn Gly Cys His

C15H23N7O6S (429.143)

Asn Gly His Cys

C15H23N7O6S (429.143)

Asn His Cys Gly

C15H23N7O6S (429.143)

Asn His Gly Cys

C15H23N7O6S (429.143)

Asn Pro Cys Pro

C17H27N5O6S (429.1682)

Asn Pro Pro Cys

C17H27N5O6S (429.1682)

Pro Cys Asn Pro

C17H27N5O6S (429.1682)

Pro Cys Pro Asn

C17H27N5O6S (429.1682)

Pro Asn Cys Pro

C17H27N5O6S (429.1682)

Pro Asn Pro Cys

C17H27N5O6S (429.1682)

Pro Pro Cys Asn

C17H27N5O6S (429.1682)

Pro Pro Asn Cys

C17H27N5O6S (429.1682)

Sulfamethoxazole glucuronide

C16H19N3O9S (429.0842)

Sulfamethoxazole N glucuronide

C16H19N3O9S (429.0842)

14-carboxy-15,16,17,18,19,20-hexanor-N-acetyl-leukotriene E4

C19H27NO8S (429.1457)

2-(4-methylpiperidin-1-yl)ethyl 6-ethyl-3-methyl-2,9-dioxo-[1,3]thiazolo[5,4-f]quinoline-8-carboxylate

C22H27N3O4S (429.1722)

Amicycline

C21H23N3O7 (429.1536)

C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

FMoc-4-Acetyl-L-phenylalanine

C26H23NO5 (429.1576)

Phenactropinium chloride

C24H28ClNO4 (429.1707)

FLORIFENINE

C23H22F3N3O2 (429.1664)

7-(Benzyloxy)-4-(4-Fluoro-2-Methyl-1h-Indol-5-Yloxy)-6-Methoxyquinazoline

C25H20FN3O3 (429.1489)

4-({[(2S,4S)-2-[2-(4-Chlorophenyl)ethyl]-2-(1H-imidazol-1-ylmethy l)-1,3-dioxolan-4-yl]methyl}sulfanyl)aniline

C22H24ClN3O2S (429.1278)

2-(((1-(TERT-BUTOXY)-2-METHYL-1-OXOPROPAN-2-YL)OXY)IMINO)-2-(2-((TERT-BUTOXYCARBONYL)AMINO)THIAZOL-4-YL)ACETIC ACID

C18H27N3O7S (429.157)

PRT062607 (P505-15, BIIB057) HCl

C19H24ClN9O (429.1792)

alx 5407 hydrochloride

C24H25ClFNO3 (429.1507)

2-(2-ETHOXY-1-BUTENYL)-5-PHENYL-3-(3-SULFOBUTYL)BENZOXAZOLIUM INNER SALT

C23H27NO5S (429.161)

2-[4-[(2-chloro-4-nitrophenyl)azo]-N-(2-cyanoethyl)-3-methylanilino]ethyl acetate

C20H20ClN5O4 (429.1204)

(2-DIMETHYLAMINO-4-NITROPHENYL) PHOSPHORIC ACID DIAMMONIUM SALT MONOHYDRATE

C8H25N5O11P2 (429.1026)

Zofenopril

C22H23NO4S2 (429.1068)

C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

4-nitrooxybutyl 2-(5-hydroxy-4-oxo-2-phenylchromen-7-yl)oxyacetate

C21H19NO9 (429.106)

N-(2-Benzoyl-4-nitrophenyl)-1,3-dihydro-1,3-dioxo-2H-isoindole-2-acetamide

C23H15N3O6 (429.0961)

tert-Butyl 2-(4-((2-chloro-4-fluorobenzyl)oxy)phenylsulfonamido)acetate

C19H21ClFNO5S (429.0813)

Erlotinib hydrochloride

C22H24ClN3O4 (429.1455)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents

acridinyl anisidide

C21H20ClN3O3S (429.0914)

Bis(4-tert-butylphenyl)iodonium chloride

C20H27ClI+ (429.0846)

[4-(2,4-difluorophenyl)-2-(phenylcarbamoyl)phenyl] benzoate

C26H17F2NO3 (429.1176)

Fmoc-amino-PEG3-CH2COOH

C23H27NO7 (429.1787)

4-Chloromethyl-n-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide

C24H20ClN5O (429.1356)

7-Didemethyl Minocycline

C21H23N3O7 (429.1536)

Anthrimide

C28H15NO4 (429.1001)

3-[N-(2-hydroxyethyl)-4-[(6-methylsulfonyl-1,3-benzothiazol-2-yl)diazenyl]anilino]propanenitrile

C19H19N5O3S2 (429.0929)

Kudzu Root P.E

C24H28ClNO4 (429.1707)

ethyl 1,4-dihydro-7-[(S,S)-3-methoxy-4-methylamino-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylate

C20H23N5O4S (429.1471)

resorcin blue, pure

C24H15NO7 (429.0848)

methyl 1-[(2-carbamoylbiphenyl-4-yl)methyl]-2-ethoxybenzimidazole-7-carboxylate

C25H23N3O4 (429.1688)

[(1H-Benzotriazol-1-yl)methyl]triphenylphosphonium Chloride

C25H21ClN3P (429.1162)

FMOC-DL-4-ACETYLPHENYLALANINE

C26H23NO5 (429.1576)

Phosphonic acid, P,P-(dichloromethylene)bis-, compd. with N,N-dibutyl-1-butanamine (1:1)

C13H31Cl2NO6P2 (429.1004)

(alphaZ)-5-Amino-alpha-[(triphenylmethoxy)imino]-1,2,4-thiadiazole-3-acetic acid ion(1-)

C23H17N4O3S (429.1021)

3-Methoxymethoxy-2-tributylstannylpyridine

C19H35NO2Sn (429.169)

2-[[(3aR,4S,6R,6aS)-6-(7-chloro-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]ethanol

C17H24ClN5O4S (429.1237)

(Z)-2-(2-Aminothiazole-4-yl-)-2-trityloxyimino acetic acid

C24H19N3O3S (429.1147)

3-(4-chlorophenyl)-9-(4-phenylphenyl)carbazole

C30H20ClN (429.1284)

2-[3-(1H-imidazol-5-yl)propyl]-1-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine,trihydrochloride

C14H26Cl3N7S (429.1036)

3,8-DI-(ETHOXYCARBONYLAMINO)-6-PHENYLPHENANTHRIDINE

C25H23N3O4 (429.1688)

2-(Fmoc-amino)-2-(1,1-dioxo-4-tetrahydrothiopyranyl)acetic Acid

C22H23NO6S (429.1246)

Funapide

C22H14F3NO5 (429.0824)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

StemRegenin 1

C24H23N5OS (429.1623)

2-(((4-(2,2-dimethyl-1,3-dioxan-5-yl)methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzimidazole

C22H27N3O4S (429.1722)

Rac-N-Methyllaudanosolinium Trifluoroacetate

C20H22F3NO6 (429.1399)

A natural product found in Gnetum montanum.

N-(4-fluoro-3-(6-pyridin-2-yl-(1,2,4)triazolo(1,5-a)pyrimidin-2-yl)phenyl)-2,4-dimethyl-1,3-oxazole-5-carboxamide

C22H16FN7O2 (429.1349)

4-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-N-(4,6-dimethyl-2-pyridinyl)-1-piperazinecarbothioamide

C18H19ClF3N5S (429.1002)

2-Furanyl-[4-[(6-hydroxy-2-methyl-5-thiazolo[3,2-b][1,2,4]triazolyl)-thiophen-2-ylmethyl]-1-piperazinyl]methanone

C19H19N5O3S2 (429.0929)

Serratiochelin

C21H23N3O7 (429.1536)

Thioxanthene-2-sulfonamide, N,N-dimethyl-9-(3-(1-piperazinyl)propylidene)-, (E)-

C22H27N3O2S2 (429.1545)

[4-(4-Acetylamino-phenyl)-3,5-dioxo-4-aza-tricyclo[5.2.2.0 2,6]undec-1-ylcarbamoyloxy]-acetic acid

C21H23N3O7 (429.1536)

2-{[(6-Oxo-1,6-Dihydropyridin-3-Yl)methyl]amino}-N-[4-Propyl-3-(Trifluoromethyl)phenyl]benzamide

C23H22F3N3O2 (429.1664)

(2-Mercaptomethyl-4-phenyl-butyrylimino)-(5-tetrazol-1-ylmethyl-thiophen-2-yl)-acetic acid

C19H19N5O3S2 (429.0929)

(2S,5R,6R)-6-({(6S)-6-[(ammonioacetyl)amino]-6-carboxylatohexanoyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C17H25N4O7S- (429.1444)

Ipratropium bromide hydrate

C20H32BrNO4 (429.1515)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents

N-phenyl-5-(7-piperidin-4-yloxyisoquinolin-6-yl)thiophene-2-carboxamide

C25H23N3O2S (429.1511)

9-Ribosyl-trans-zeatin 5-phosphate(2-)

C15H20N5O8P-2 (429.1049)

Mannosylglucosylglycerate

C15H25O14- (429.1244)

N-acetyl-L-aspartyl-L-glutamyl-L-glutamate

C16H19N3O11-4 (429.102)

2-O-[alpha-D-Glucopyranosyl-(1->6)-alpha-D-glucopyranosyl]-D-glycerate

C15H25O14- (429.1244)

cZRMP

C15H20N5O8P-2 (429.1049)

Tridemethylpuromycin

C19H23N7O5 (429.1761)

(2-Amino-3-oxopropyl) [3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butyl] hydrogen phosphate

C14H28N3O8PS (429.1335)

(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(2,5-dihydroxy-3-methylphenyl)sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

C17H23N3O8S (429.1206)

4-[({2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-1,3-dioxolan-4-yl}methyl)sulfanyl]aniline

C22H24ClN3O2S (429.1278)

[3,4-dihydroxy-5-[6-[[(E)-4-hydroxy-3-methylbut-2-enyl]amino]purin-9-yl]oxolan-2-yl]methyl phosphate

C15H20N5O8P-2 (429.1049)

Tarceva

C22H24ClN3O4 (429.1455)

D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents

tarocin A2

C22H18F3N3O3 (429.13)

3-(2-Benzo[1,3]dioxol-5-yl-3,5-dihydroxy-4-oxo-4H-chromen-7-yloxymethyl)-benzonitrile

C24H15NO7 (429.0848)

[5-[(4-Methoxyphenyl)methylamino]-3-phenyl-1,2,4-triazol-1-yl]-(4-nitrophenyl)methanone

C23H19N5O4 (429.1437)

3-[2-[4-(2-Chloro-4-nitrophenyl)-1-piperazinyl]ethoxy]-4-phenyl-1,2,5-oxadiazole

C20H20ClN5O4 (429.1204)

1-Ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid methanesulfonate

C18H24FN3O6S (429.137)

1-[2-[[(2,4-Dichloroanilino)-oxomethyl]amino]-2-methyl-1-oxopropyl]-4-piperidinecarboxylic acid ethyl ester

C19H25Cl2N3O4 (429.1222)

N-[3-(4-morpholinylsulfonyl)phenyl]-4-(2-oxo-1-pyrrolidinyl)benzamide

C21H23N3O5S (429.1358)

2-[[4-(4-fluorophenyl)-5-[(1-methyl-2-pyrrolyl)methyl]-1,2,4-triazol-3-yl]thio]-N-(2-oxolanylmethyl)acetamide

C21H24FN5O2S (429.1635)

N-(2-ethylphenyl)-2-[[2-(4-methoxyphenyl)-4-oxo-1-benzopyran-6-yl]oxy]acetamide

C26H23NO5 (429.1576)

N-[2-methoxy-5-(3-methyl-4-oxo-1-phthalazinyl)phenyl]-2-(4-methylphenoxy)acetamide

C25H23N3O4 (429.1688)

{[(1r,7r)-4-(4-Acetamidophenyl)-3,5-dioxo-4-azatricyclo[5.2.2.0(2,6)]undec-1-yl]carbamoyloxy}acetic acid

C21H23N3O7 (429.1536)

N-(3-carbamoyl-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-3-(2-chlorophenyl)-5-methyl-4-isoxazolecarboxamide

C21H20ClN3O3S (429.0914)

methyl 3-[[2-[1,3-benzodioxol-5-yl(ethyl)amino]acetyl]amino]-5-chloro-1H-indole-2-carboxylate

C21H20ClN3O5 (429.1091)

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[[1-(3,4-dimethoxyphenyl)-5-tetrazolyl]thio]acetamide

C19H19N5O5S (429.1107)

2-[[(4-ethoxyphenyl)-oxomethyl]amino]acetic acid [2-(9H-fluoren-3-yl)-2-oxoethyl] ester

C26H23NO5 (429.1576)

4-[(4-chlorophenyl)methyl-methylsulfonylamino]-N-(2-pyridinylmethyl)benzamide

C21H20ClN3O3S (429.0914)

2-chloro-N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-5-(1,2,4-triazol-4-yl)benzamide

C23H16ClN5O2 (429.0992)

N-(phenylmethyl)-2-[[4-(trifluoromethyl)-5,6-dihydrobenzo[h]quinazolin-2-yl]thio]acetamide

C22H18F3N3OS (429.1123)

3,4,5-trimethoxy-N-[[[(1S,2S)-2-phenylcyclopropanecarbonyl]amino]carbamothioyl]benzamide

C21H23N3O5S (429.1358)

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[4-(4-morpholinyl)phenyl]-3-imidazo[1,2-a]pyrazinamine

C24H23N5O3 (429.1801)

2-(2-Bromophenyl)-3-[3-(4-morpholinyl)propyl]-1,2-dihydroquinazolin-4-one

C21H24BrN3O2 (429.1052)

2-[2-oxo-6-(1-pyrrolidinylsulfonyl)-1,3-benzoxazol-3-yl]-N-(1-phenylethyl)acetamide

C21H23N3O5S (429.1358)

N-[2,5-diethoxy-4-[[(2-furanylmethylamino)-sulfanylidenemethyl]amino]phenyl]-2-furancarboxamide

C21H23N3O5S (429.1358)

3-[(2S,4S)-2-(4-hydroxybutoxy)-6-[4-morpholinyl(oxo)methyl]-3,4-dihydro-2H-pyran-4-yl]-1-benzopyran-4-one

C23H27NO7 (429.1787)

D-xylotrionate

C15H25O14- (429.1244)

N-(18-Phenyl-11-oxa-13,15-diazatetracyclo[8.8.0.02,7.012,17]octadeca-1(10),2,4,6,8,12,14,16-octaen-16-yl)benzamide

C28H19N3O2 (429.1477)

3-O-acetyl-8-O-demethylmaritidine Trifluoroacetic acid

C20H22F3NO6 (429.1399)

A natural product found in Crinum asiaticum var. sinicum.

(2R)-2-O-[alpha-D-glucopyranosyl-(1->6)-alpha-D-glucopyranosyl]-glycerate

C15H25O14- (429.1244)

(4-(2,5-Di(furan-2-yl)pyrazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl)(furan-3-yl)methanone

C23H19N5O4 (429.1437)

Bispyribac anion

C19H17N4O8- (429.1046)

2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(2-methoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid methyl ester

C19H27NO8S (429.1457)

3-[4-[(1R,5S)-3-(2-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

C25H23N3O2S (429.1511)

4-[4-[(1S,5R)-3-(phenylmethyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

C25H23N3O2S (429.1511)

4-[4-[(1R,5S)-3-(2-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

C25H23N3O2S (429.1511)

methyl 2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(2-methoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetate

C19H27NO8S (429.1457)

4-[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile

C22H27N3O4S (429.1722)

2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(2-methoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid methyl ester

C19H27NO8S (429.1457)

methyl 2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(2-methoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetate

C19H27NO8S (429.1457)

(2S)-2-[(4S,5S)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C22H27N3O4S (429.1722)

(2S)-2-[(4S,5R)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C22H27N3O4S (429.1722)

(2R)-2-[(4S,5R)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C22H27N3O4S (429.1722)

[(1S,2aS,8bS)-2-(1,3-benzodioxol-5-ylmethyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-pyridinyl)methanone

C25H23N3O4 (429.1688)

2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(2-methoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid methyl ester

C19H27NO8S (429.1457)

(2R)-2-[(4S,5S)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C22H27N3O4S (429.1722)

(2S)-2-[(4R,5R)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C22H27N3O4S (429.1722)

(2R)-2-[(4R,5S)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C22H27N3O4S (429.1722)

(2S)-2-[(4R,5S)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C22H27N3O4S (429.1722)

(2R)-2-[(4R,5R)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C22H27N3O4S (429.1722)

[(1R,2aR,8bR)-2-(1,3-benzodioxol-5-ylmethyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-pyridinyl)methanone

C25H23N3O4 (429.1688)

[(1S,2aR,8bR)-2-(1,3-benzodioxol-5-ylmethyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-pyridinyl)methanone

C25H23N3O4 (429.1688)

[(1R,2aS,8bS)-2-(1,3-benzodioxol-5-ylmethyl)-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-4-yl]-(3-pyridinyl)methanone

C25H23N3O4 (429.1688)

2-[(2R,4aR,12aR)-5-methyl-8-[[(5-methyl-3-isoxazolyl)-oxomethyl]amino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid

C21H23N3O7 (429.1536)

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(2-methoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid methyl ester

C19H27NO8S (429.1457)

2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(2-methoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid methyl ester

C19H27NO8S (429.1457)

3-Dehydroisovitexin

C21H17O10- (429.0822)

Benzylpenicilloyl-butylamine sodium

C20H28N3NaO4S (429.1698)

2-methyl-5-oxo-7-thiophen-2-yl-4-(3-thiophenyl)-4,6,7,8-tetrahydro-3H-quinoline-3-carboxylic acid 2-methoxyethyl ester

C22H23NO4S2 (429.1068)

methyl 2-[(6-O-alpha-D-mannopyranosyl-alpha-D-mannopyranosyl)thio]ethanimidate

C15H27NO11S (429.1305)

2-Chloro-N-[3-[(Z)-2-cyano-3-oxo-3-(2-phenylethylamino)prop-1-enyl]phenyl]benzamide

C25H20ClN3O2 (429.1244)

5-[[4-[(E)-2-(1H-benzimidazol-2-yl)-2-cyanoethenyl]-2-ethoxyphenoxy]methyl]furan-2-carboxylic acid

C24H19N3O5 (429.1325)

2-[(E)-(2-oxo-1H-indol-3-ylidene)amino]-N-(2-phenylethyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

C25H23N3O2S (429.1511)

N-[4-[[5-[3-(2-aminoethyl)-1H-indol-5-yl]-1,2,4-oxadiazol-3-yl]methyl]phenyl]methanesulfonamide;hydrate

C20H23N5O4S (429.1471)

9-Ribosyl-trans-zeatin 5-phosphate(2-)

C15H20N5O8P (429.1049)

A organophosphate oxoanion that is that is AMP(2-) substituted at position N-6 by a (2E)-4-hydroxy-3-methylbut-2-en-1-yl group; major species at pH 7.3.

Sulfamethoxazole N1-glucuronide

C16H19N3O9S (429.0842)

2-O-[alpha-D-mannosyl-(1->2)-alpha-D-glucosyl]-D-glycerate

C15H25O14 (429.1244)

A carbohydrate acid derivative anion that is the conjugate base of 2-O-[alpha-D-mannosyl-(1->2)-alpha-D-glucosyl]-D-glyceric acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

LPS 8:2;O3

C14H24NO12P (429.1036)

LPS 9:1;O2

C15H28NO11P (429.14)

ST 21:6;O5;Gly

C23H27NO7 (429.1787)

Befiradol (hydrochloride)

C20H23Cl2F2N3O (429.1186)

Befiradol hydrochloride (NLX-112 hydrochloride) is a selective 5-HT1A receptor agonist.

Ipratropium (bromide hydrate)

C20H32BrNO4 (429.1515)

Ipratropium bromide (Sch 1000) hydrate is a muscarinic receptor antagonist, with IC50s of 2.9 nM, 2 nM, and 1.7 nM for M1, M2, and M3 receptors, respectively. Ipratropium bromide hydrate relaxes smooth muscle, can be used in the research for COPD (chronic obstructive pulmonary disease) and asthma[1][2][3][4][5].

UBP316

C20H19N3O6S (429.0995)

UBP316 (ACET) is a highly potent and selective kainate receptor GluK1 (GluR5) antagonist, with a Kb value of 1.4 nM. UBP316 is effective at blocking the depression of both field excitatory postsynaptic potentials (fEPSPs) and monosynaptically-evoked GABAergic transmission induced by ATPA, a GluK1 selective agonist[1].

(1s,11r,13s,14s,15r,19r)-14,15-dimethoxy-20-methyl-19-(2-oxopropyl)-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-trien-16-one

C23H27NO7 (429.1787)

(5r)-3-methyl-5-[(23s)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaen-23-yl]-5h-furan-2-one

C25H19NO6 (429.1212)

1-acetyl-5-hydroxy-6-[(2r,4r,5s,6r)-5-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]-3-methylnaphtho[2,3-c]thiophene-4,9-dione

C22H23NO6S (429.1246)

(3s,12r,27s)-12,26-dihydroxy-3-methyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C23H19N5O4 (429.1437)

12,26-dihydroxy-3-methyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C23H19N5O4 (429.1437)

2-[(1-hydroxy-2-{[hydroxy(5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl)methylidene]amino}-3-(c-hydroxycarbonimidoyl)propylidene)amino]-3-(1h-indol-3-yl)propanoic acid

C20H23N5O6 (429.1648)

6-[2,3-dihydroxy-3-(4-hydroxy-2-imino-1h-pteridin-6-yl)propoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H19N5O10 (429.1132)

1-(2-amino-1-benzofuran-3-yl)-2-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethanone

C22H23NO8 (429.1424)

3-nitropropyl allolactoside

C15H27NO13 (429.1482)

{"Ingredient_id": "HBIN008981","Ingredient_name": "3-nitropropyl allolactoside","Alias": "NA","Ingredient_formula": "C15H27NO13","Ingredient_Smile": "NA","Ingredient_weight": "429.377","OB_score": "NA","CAS_id": "117845-08-O","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8027","PubChem_id": "NA","DrugBank_id": "NA"}

acuminaminoside

C22H23NO8 (429.1424)

{"Ingredient_id": "HBIN014647","Ingredient_name": "acuminaminoside","Alias": "NA","Ingredient_formula": "C22H23NO8","Ingredient_Smile": "C1=CC=C(C(=C1)CC(=O)C2=C(OC3=CC=CC=C32)N)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "429.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "590","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21577089","DrugBank_id": "NA"}

(5s,8r,9s)-8-benzoyl-2-[(1z,3z)-1,4-dihydroxyhexa-1,3-dien-1-yl]-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C22H23NO8 (429.1424)

8-benzoyl-2-(1,4-dihydroxyhexa-1,3-dien-1-yl)-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C22H23NO8 (429.1424)

(1s,3s,12r,14r,27s)-12,26-dihydroxy-3-methyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C23H19N5O4 (429.1437)

methyl 5-[(1e)-2-{6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}-1,2-dihydroxyethenyl]-2h-1,3-benzodioxole-4-carboxylate

C22H23NO8 (429.1424)

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-{[(9r)-16-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-15-yl]oxy}oxane-3,4,5-triol

C23H27NO7 (429.1787)

2-(3-chlorophenyl)-3-[2-(hydroxymethyl)-3-methoxyphenyl]-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

C26H20ClNO3 (429.1132)

14,15-dimethoxy-20-methyl-19-(2-oxopropyl)-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-trien-16-one

C23H27NO7 (429.1787)

2-(cyanomethylidene)-5,6-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexyl 3-methylbut-2-enoate

C19H27NO10 (429.1635)

2,5-dimethyl 3-(5-hydroxy-1h-indol-3-yl)-4-(1h-indol-3-yl)-1h-pyrrole-2,5-dicarboxylate

C24H19N3O5 (429.1325)

[16-(hydroxymethyl)-3,17,18-trimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15(20),16,18-hexaen-19-yl]methanol

C23H27NO7 (429.1787)

(2s,3s,4s,5r,6r)-6-[(2r,3r)-2,3-dihydroxy-3-(4-hydroxy-2-imino-1h-pteridin-6-yl)propoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H19N5O10 (429.1132)

methyl 4,5,14,15,16-pentamethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-10-carboxylate

C23H27NO7 (429.1787)

(2s)-2-{[(2s)-1-hydroxy-2-({hydroxy[(2s)-5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl]methylidene}amino)-3-(c-hydroxycarbonimidoyl)propylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C20H23N5O6 (429.1648)

(1s,3r,12r,14r,27s)-12,26-dihydroxy-3-methyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C23H19N5O4 (429.1437)

2-fluorocyclohexyl n-(4-{[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}phenyl)carbamate

C20H28FNO8 (429.1799)

1-acetyl-5-hydroxy-6-[5-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]-3-methylnaphtho[2,3-c]thiophene-4,9-dione

C22H23NO6S (429.1246)

(1r,2r)-2-fluorocyclohexyl n-(4-{[(2s,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}phenyl)carbamate

C20H28FNO8 (429.1799)

2,12,16,19,29-pentaazaoctacyclo[15.13.1.1¹⁸,²⁶.0¹,¹⁰.0³,⁸.0¹³,³¹.0²⁰,²⁵.0³⁰,³²]dotriaconta-3,5,7,13(31),16,18,20(25),21,23,26(32),27,29-dodecaen-9-one

C27H19N5O (429.159)

(1s,3s,12s,14s,27s)-12,26-dihydroxy-3-methyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C23H19N5O4 (429.1437)

methyl (9s)-4,5,14,15,16-pentamethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaene-10-carboxylate

C23H27NO7 (429.1787)

(1s,10s)-2,12,16,19,29-pentaazaoctacyclo[15.13.1.1¹⁸,²².0¹,¹⁰.0³,⁸.0¹³,³¹.0²³,²⁸.0³⁰,³²]dotriaconta-3,5,7,13(31),16,18,20,22(32),23(28),24,26,29-dodecaen-9-one

C27H19N5O (429.159)

2-(4-chlorophenyl)-3-[2-(hydroxymethyl)-3-methoxyphenyl]-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

C26H20ClNO3 (429.1132)

methyl 5-(2-{6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}-1,2-dihydroxyethenyl)-2h-1,3-benzodioxole-4-carboxylate

C22H23NO8 (429.1424)

[(1s)-16-(hydroxymethyl)-3,17,18-trimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁵,²⁰]henicosa-2,4(8),9,15(20),16,18-hexaen-19-yl]methanol

C23H27NO7 (429.1787)

3-methyl-5-{24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaen-23-yl}-5h-furan-2-one

C25H19NO6 (429.1212)

3-(cyanomethylidene)-2,6-dihydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexyl 3-methylbut-2-enoate

C19H27NO10 (429.1635)

(5r)-3-methyl-5-[(23r)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaen-23-yl]-5h-furan-2-one

C25H19NO6 (429.1212)

4-(cyanomethylidene)-2,3-dihydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexyl 3-methylbut-2-enoate

C19H27NO10 (429.1635)

(1s,2e,3r,5s,6s)-2-(cyanomethylidene)-5,6-dihydroxy-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexyl 3-methylbut-2-enoate

C19H27NO10 (429.1635)

5-(2-{2-[2-(dimethylamino)ethyl]-4,5-dimethoxyphenyl}-2-oxoacetyl)-2h-1,3-benzodioxole-4-carboxylic acid

C22H23NO8 (429.1424)

(9s,12s,15s)-9-amino-4,10,13-trihydroxy-12-(hydroxymethyl)-2-oxa-11,14-diazatricyclo[15.2.2.1³,⁷]docosa-1(19),3(22),4,6,10,13,17,20-octaene-15-carboxylic acid

C21H23N3O7 (429.1536)

2-hydroxy-n-[(9s)-5,13,19-trimethoxy-6-oxo-15,17-dioxatetracyclo[10.7.0.0²,⁸.0¹⁴,¹⁸]nonadeca-1(19),2,4,7,12,14(18)-hexaen-9-yl]ethanimidic acid

C22H23NO8 (429.1424)

(1s,2r,3s,4z,5r)-4-(cyanomethylidene)-2,3-dihydroxy-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexyl 3-methylbut-2-enoate

C19H27NO10 (429.1635)

(1s,11s,13s,14r,15r,19r)-14,15-dimethoxy-20-methyl-19-(2-oxopropyl)-5,7,21-trioxa-20-azahexacyclo[11.4.3.1¹¹,¹⁴.0¹,¹³.0²,¹⁰.0⁴,⁸]henicosa-2,4(8),9-trien-16-one

C23H27NO7 (429.1787)

1-(2-amino-1-benzofuran-3-yl)-2-(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethanone

C22H23NO8 (429.1424)

(1s,2s,3z,4r,6s)-3-(cyanomethylidene)-2,6-dihydroxy-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexyl 3-methylbut-2-enoate

C19H27NO10 (429.1635)

(1r,3s,12r,14s,27s)-12,26-dihydroxy-3-methyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C23H19N5O4 (429.1437)

(14s)-14-(methoxycarbonyl)-9-methyl-12-oxo-14-phenyl-13-oxa-2,9-diazatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7,11(15),16-hexaene-4-carboximidic acid

C24H19N3O5 (429.1325)